Checkmate raises $27M, names COO

Checkmate Pharmaceuticals Inc. (Cambridge, Mass.) raised $27 million in a series B round led by new investor F-Prime Capital Partners. Existing investors Sofinnova Ventures and venBio also participated.

Checkmate also named Karen Brennan COO. She was VP of clinical and development operations at Forum Pharmaceuticals Inc. (Waltham, Mass.)...